Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for HK inno.N

    Client Virtual Booth

    HK INNO.N

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    HK inno.N
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    (04551) 100, Eulji-ro, Jung-gu, Seoul
    Telephone
    Telephone
    +82-2-6477-0000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.inno-n.com/eng/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    GICELL Announces Collaboration with HK inno.N for next-generation CAR-NK therapy
    GICELL Announces Collaboration with HK inno.N for next-generation CAR-NK therapy

    https://www.businesswire.com/news/home/20220829005272/en

    BUSINESSWIRE
    29 Aug 2022
    Share Share
    After $500M IPO, HK inno.N enters exosome drug delivery
    After $500M IPO, HK inno.N enters exosome drug delivery

    https://www.fiercepharma.com/pharma/after-500m-ipo-hk-innon-enters-exosome-drug-delivery-ilias-pact

    Nick Paul Taylor FIERCEPHARMA
    31 May 2022
    Share Share
    Dr. Reddy's signs multi-country deal for GE in India & Emerging Markets
    Dr. Reddy's signs multi-country deal for GE in India & Emerging Markets

    https://www.biospectrumasia.com/news/25/20337/dr-reddys-signs-multi-country-deal-for-gastroenterology-in-india-select-emerging-markets.html

    BIOSPECTRUMASIA
    19 May 2022
    Share Share
    Dr. Reddy’s Laboratories to commercialise novel molecule Tegoprazan in India
    Dr. Reddy’s Laboratories to commercialise novel molecule Tegoprazan in India

    https://www.financialexpress.com/healthcare/pharma-healthcare/dr-reddys-laboratories-to-commercialise-novel-molecule-tegoprazan-in-india/2520304/

    FINANCIAL EXPRESS
    11 May 2022
    Share Share
    K-CAB becomes blockbuster drug topping ?100 billion in annual sales
    K-CAB becomes blockbuster drug topping ?100 billion in annual sales

    http://www.koreabiomed.com/news/articleView.html?idxno=12972

    Lee Han-soo KOREABIOMED
    17 Jan 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search